Article Text
PostScript
Letters
Routine probiotics in preterm infants?
Statistics from Altmetric.com
A commissioned commentary by Millar et al1 and a recent statement from the American Academy of Pediatrics2 complain about the lack of defined probiotic products that are licensed by regulatory authorities. A commercially available combination of Lactobacillus acidophilus and Bifidusbacterium infantis (Infloran), given to a total of 1725 preterm infants within the framework of two open-label and two randomised controlled trials without side effects,3 has been shown to reduce necrotising enterocolitis (NEC) and …
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.